DLOC BIOSYSTEMS LTD
Company number 14670245 · Monitor this company
Executive summary
DLOC BIOSYSTEMS LTD is an early-stage biotechnology start-up showing typical financial distress symptoms such as negative working capital and equity due to high R&D investment. While the company depends on related-party funding, it must strengthen liquidity and accelerate commercialization to improve its financial wellness. With strategic funding and operational focus, the company has potential to stabilize and grow.
Shareholders' funds
-£50,396
Balance sheet as at 2026-02-28
Overview
- Company type
- Private Limited Company
- Incorporated
- 2023-02-17
- Employees
- 5 (2026 accounts · was 7 in 2025)
- Registered office
- Innovation House Innovation Way, Discovery Park, Sandwich, Kent, CT13 9FF
- Postcode
- CT13 9FF
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2026-02-28
- Next due by
- 2027-11-30
- Financial year end
- 28 February
Confirmation statement
- Last statement dated
- 2026-02-17
- Next due by
- 2027-03-03
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 2 current · 2 resigned
Contact details
- Website
- dlocbiosystems.com
DLOC Biosystems is a preclinical CRO that invented and patented a new organ-on-chip technology for growing 3D tissues and organ systems with microenvironments resembling the human body. DLOC's chips incorporate ultra-thin 3D porous scaffolds, allowing accurate tissue growth. DLOC's AI-powered operating systems allow for connecting different organ chips, modelling the human body, and predicting drug effects.
At this address
Among the biggest employers
of 18 similar companies in CT, with 5 staff.
Competitors Canterbury
This company ranks 22 among research and experimental development on biotechnology in Canterbury.